|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Richard Pates (Cardiff and Vale NHS Trust) , Diane Riley (University of Toronto)Publisher: John Wiley and Sons Ltd Imprint: Wiley-Blackwell Dimensions: Width: 17.40cm , Height: 1.60cm , Length: 24.60cm Weight: 0.463kg ISBN: 9781405175586ISBN 10: 1405175583 Pages: 256 Publication Date: 14 August 2009 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Out of Print Availability: In Print ![]() Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock. Table of ContentsContributors. Dedication. Acknowledgements. 1. Introduction (Richard Pates and Diane Riley). 2. The physical effects of amphetamine use (Zoe Hildrey, Sophie E. Thomas and Alyson Smith). 3. The psychological and psychiatric effects of amphetamines (Richard Pates and Diane Riley). 4. The mechanisms of amphetamine in the brain (Jan K. Melichar and David J. Nutt). 5. Methylphenidate for the treatment of ADHD: clinical efficacy, abuse potential and consequences of use (Craig R. Rush, Andrea R. Vansickel, William W. Stoops and Paul E. A. Glaser). 6. Amphetamine treatment in the UK: the role of substitute prescribing (Richard Pates). 7. Treatments for methamphetamine dependence: contingency management and the matrix model (Richard A. Rawson). 8. Amphetamine use in Canada (Diane Riley). 9. Treatment responses to problematic methamphetamine use: the Australian experience (James Shearer). 10. The ‘P’ problem in New Zealand (Chris Wilkins and Janie Sheridan). 11 Japan’s long association with amphetamines: what can we learn from their experiences? (Akihiko Sato). 12. The emergence of methamphetamine in Thailand: interventions and treatment (Anjalee Cohen and Catherine McGregor). 13. Stimulant use in Central and Eastern Europe: how recent social history shaped current drug consumption patterns (Jean-Paul Grund, Tomas Zabransky, Kevin S. Irwin and Robert Heimer). 14. Sweden’s long experience of amphetamine problems (Kerstin Käll). 15. Harm reduction and amphetamines (Diane Riley). 16. What have we learned: conclusions on treatment (Diane Riley and Richard Pates). Index.ReviewsAuthor InformationRichard Pates is a consultant clinical psychologist and clinical director of the Addiction services for Cardiff and vale NHS Trust. He has worked in the field for nearly 20 years and has extensive experience of treating people with amphetamine problems. His research interests include the treatment of amphetamine problems and aspects of injecting. He is also editor of The Journal of Substance Use. Diane Riley is the Director of the Harm Reduction Network, a policy analyst with the Canadian Foundation for Drug Policy and the International Harm Reduction Association, and a Professor in the Faculty of Medicine at the University of Toronto, Canada. Tab Content 6Author Website:Countries AvailableAll regions |